Champions Oncology announces $5M share repurchase program through April 2024

CHAMPIONS ONCOLOGY, INC.

Board authorized up to $5M of common stock repurchases through April 30, 2024.
Purchases will be made in open market transactions under Rule 10b-18.
CEO Ronnie Morris cites confidence in strategic priorities and long-term prospects.
CFO David Miller notes balance sheet strength and current valuation as buying opportunity.
Program may be suspended, modified, or terminated at any time without notice.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.